Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model

Fig. 2

Effects of MAG- ω3 treatments on pro-inflammatory cytokine levels. (a) IL-17A, (b) IL-1β, (c) IL-6 and (d) TNFα levels were assessed in plasma of control, complete Freund’s adjuvant (CFA)-treated, CFA + eicosapentaenoic acid monoglyceride (MAG-EPA)-treated, CFA + docosahexaenoic acid monoglyceride (MAG-DHA)-treated and CFA + -docosapentaenoic acid monoglyceride (MAG-DPA)-treated rats using specific ELISA as described in the Methods section (n = 6, *P ≤0.05)

Back to article page